KD-CAAP is the first investigator driven trial funded by conect4children to have a site activated and to start the patients’ recruitment. KD-CAAP main objective is to determine whether adding immediate corticosteroid treatment to standard of care (intravenous immunoglobulin (IVIG) and aspirin) will reduce coronary artery aneurysm (CAA) rates in Kawasaki Disease patients.
Find more about this trial here: http://kdcaap.mrcctu.ucl.ac.uk/
Read the full press release here: https://conect4children.org/news/pr_kdcaapp_09_2020/
